Aripiprazole Treatment for Obsessive Compulsive Disorder in 2 Young Subjects Who Could Not Tolerate Selective Serotonin Reuptake Inhibitors (SSRIs).
作者信息
Coskun Murat, Karayagmurlu Ali
出版信息
J Clin Psychopharmacol. 2020 May/Jun;40(3):310-312. doi: 10.1097/JCP.0000000000001210.
PMID:32332471
Abstract
摘要
相似文献
1
Aripiprazole Treatment for Obsessive Compulsive Disorder in 2 Young Subjects Who Could Not Tolerate Selective Serotonin Reuptake Inhibitors (SSRIs).
J Clin Psychopharmacol. 2020 May/Jun;40(3):310-312. doi: 10.1097/JCP.0000000000001210.
2
Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
Prescrire Int. 2000 Aug;9(48):112-3.
3
Sertraline-induced enuresis in a prepubertal child resolves after switching to fluoxetine.
J Child Adolesc Psychopharmacol. 2010 Apr;20(2):161-2. doi: 10.1089/cap.2009.0031.
4
Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
Prescrire Int. 2004 Oct;13(73):163-5.
5
Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
J Clin Psychopharmacol. 2002 Apr;22(2):148-54. doi: 10.1097/00004714-200204000-00007.
6
Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
Depress Anxiety. 2008;25(2):172-4. doi: 10.1002/da.20303.
7
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
J Clin Psychiatry. 2004 Oct;65(10):1365-71. doi: 10.4088/jcp.v65n1011.
8
Sertraline induced cervical dystonia in a patient of Obsessive Compulsive Disorder.
Asian J Psychiatr. 2018 Jan;31:77-78. doi: 10.1016/j.ajp.2018.01.018. Epub 2018 Feb 9.
9
Intermittent Electric Shock-Like Sensations Associated With Sertraline Use for Treatment of Obsessive-Compulsive Disorder.
J Clin Psychopharmacol. 2022;42(1):101-103. doi: 10.1097/JCP.0000000000001472.
10
Priapism associated with sertraline.
J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):790-1. doi: 10.1097/chi.0b013e318067da56.
引用本文的文献
1
Higher benefit-risk ratio of COVID-19 vaccination in patients with schizophrenia and major depressive disorder versus patients with bipolar disorder when compared to controls.
Am J Transl Res. 2022 Aug 15;14(8):5719-5729. eCollection 2022.
2
Olfactory Reference Syndrome (Halitophobia) With Oral Cenesthopathy Treated With Low-Dose Aripiprazole: A Case Report.
Clin Neuropharmacol. 2021;44(6):235-237. doi: 10.1097/WNF.0000000000000476.
Zotero 插件